| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4271597 | The Journal of Sexual Medicine | 2011 | 13 Pages |
Abstract
This review focuses on our current understanding of the role of the RhoA/Rhoâkinase pathway in the regulation of the male urogenital system. Rhoâkinase inhibitors may evolve into an important pharmacologic option in the future treatment of urogenital system disorders. Gur S, Kadowitz PJ, and Hellstrom WJG. RhoA/Rhoâkinase as a therapeutic target for the male urogenital tract.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Serap PhD, Philip J. PhD, Wayne J.G. MD, FACS,